Emerald Investment Advisers LLC bought a new position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,456 shares of the company’s stock, valued at approximately $2,023,000. Other institutional […]